+61 2-8964 9600 info@lucidhealthcon.com
  • Twitter
  • Linkedin
  • Twitter
  • Linkedin
Lucid Health Consulting
  • HOME
  • ABOUT
  • SERVICES
    • Reimbursement Submissions – PBAC and MSAC
    • Economic Evaluations
    • Statistical Analyses
    • Regulatory Strategy, Submissions & Compliance
    • Commercial Strategy
  • TEAM
  • ARTICLES
  • PUBLICATIONS
  • VIDEOS
  • CONTACT
Select Page
ISPOR VOS Research Round Up | September – October 2020.

ISPOR VOS Research Round Up | September – October 2020.

by George Papadopoulos | Oct 27, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director, George Papadopoulos, authored the ISPOR, Research Roundup in the September-October 2020 Edition of the Value & Outcomes Spotlight. The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE)....
6th Annual Drugs & Devices Australia Webinar, 2020 – Reimbursement Update.

6th Annual Drugs & Devices Australia Webinar, 2020 – Reimbursement Update.

by George Papadopoulos | Oct 21, 2020 | Webinars

Free Webinar: 6th Annual Drugs & Devices Australia – Reimbursement Update.   Please join us for this free webinar, hosted by Sarah Griffin, Director of MedTechnique Consulting and George Papadopoulos Partner & Director of Lucid Health Consulting as they...

Recent Posts

  • Submission to the Consultation on the Medical Services Advisory Committee (MSAC)
  • Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data
  • ISPOR VOS Research Round Up | September – October 2020.

Recent Comments

  • admin on Should discount rates be selectively applied in health economic evaluations?
  • Tim Hortons Buffalo on Should discount rates be selectively applied in health economic evaluations?

Archives

  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • Twitter
  • Linkedin
Created by Spindrift Marketing| © Lucid Health Consulting 2020